...
首页> 外文期刊>Current radiopharmaceuticals >Gallium- 68 - A new opportunity For PET available from a long shelflife generator - Automation and applications
【24h】

Gallium- 68 - A new opportunity For PET available from a long shelflife generator - Automation and applications

机译:镓-68-保质期长的发生器为PET带来的新机遇-自动化和应用

获取原文
获取原文并翻译 | 示例
           

摘要

68Ge/ 68Ga generators have received tremendous attention in the last years based on the success of 68Ga-labelled Somatostatin analogues for Positron-Emission Tomography (PET), which are today used routinely worldwide. Various commercially available generator types are based on different column matrices including TiO 2, SnO 2 or organic 68Gechelate coated silica, providing 68Ga as Ga 3+ in HCl for radiolabeling procedures. These systems can serve as a stable source of 68Ga for PET applications over periods of more than one year with high yields. A number of methods for post processing of the eluate including fractionation, anion or cation exchange purification have been developed. These methods are particularly important for high specific activity labeling of biomolecules such as peptides ensuring small volumes, low metallic contamination and low 68Ge breakthrough. These systems have been implemented into fully automated modules allowing generator elution, post processing radiolabeling and formulation, complying with high regulatory demands. Quality aspects regarding the clinical use of 68Ga for patient applications including limit of 68Ge content, metal contamination, microbiological safety and radiochemical purity have been addressed. Overall, the establishment of 68Ge/ 68Ga generator technology together with the development of novel 68Ga-radiopharmaceuticals make 68Ga a most promising radionuclide for PET in the years to come.
机译:近年来,基于68Ga标记的生长激素抑制素类似物在正电子发射断层扫描(PET)中的成功应用,使68Ge / 68Ga发生器受到了极大的关注,如今,这种类似物已在全球范围内常规使用。各种可商购的发生器类型基于不同的色谱柱基质,包括TiO 2,SnO 2或有机68Gechelate涂层的二氧化硅,在HCl中提供68Ga作为Ga 3+进行放射性标记。这些系统可以在超过一年的时间内稳定地为PET应用提供68Ga的高产来源。已经开发了许多用于洗脱液的后处理的方法,包括分馏,阴离子或阳离子交换纯化。这些方法对于确保高体积比,低金属污染和低68Ge突破的肽等生物分子的高比活标记特别重要。这些系统已实现为全自动模块,可进行发生器洗脱,后处理放射性标记和配制,并符合严格的法规要求。已经解决了有关将68Ga用于患者的临床应用的质量问题,包括68Ge含量的限制,金属污染,微生物安全性和放射化学纯度。总体而言,建立68Ge / 68Ga发生器技术以及开发新型68Ga放射性药物使68Ga成为未来几年最有前途的PET放射性核素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号